Search research articles
Contact Us
Filters
Showing results (81-90 of 157) with videos related to
Page
of 16
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 23, 2013
Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study
C Chirouze, E Athan, F Alla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2014
Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study
G Ralph Corey, Samantha Good, Hai Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 29, 2015
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality
Melinda K Lacy, Martin E Stryjewski, Whedy Wang, et al.
Archives of Internal Medicine
|
September 25, 2003
Clinical identifiers of complicated Staphylococcus aureus bacteremia
Vance G Fowler, Maren K Olsen, G Ralph Corey, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 21, 2007
Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia
Jula K Inrig, Shelby D Reed, Lynda A Szczech, et al.
International Journal of Antimicrobial Agents
|
May 22, 2018
Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections
David B Huang, G Ralph Corey, Thomas L Holland, et al.
Journal of Clinical Microbiology
|
October 23, 2009
Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial
In-Gyu Bae, Giang T Tonthat, Martin E Stryjewski, et al.
BMC Infectious Diseases
|
June 3, 2014
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
Martin E Stryjewski, Arnold Lentnek, William O'Riordan, et al.
Critical Care Medicine
|
December 20, 2007
Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia
Anna Lisa Crowley, Gail E Peterson, Daniel K Benjamin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2005
Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia
Vance G Fowler, Anita Justice, Catrin Moore, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 157) with videos related to
Sort By:
Page
of 16
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 23, 2013
Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study
C Chirouze, E Athan, F Alla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2014
Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study
G Ralph Corey, Samantha Good, Hai Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 29, 2015
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality
Melinda K Lacy, Martin E Stryjewski, Whedy Wang, et al.
Archives of Internal Medicine
|
September 25, 2003
Clinical identifiers of complicated Staphylococcus aureus bacteremia
Vance G Fowler, Maren K Olsen, G Ralph Corey, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 21, 2007
Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia
Jula K Inrig, Shelby D Reed, Lynda A Szczech, et al.
International Journal of Antimicrobial Agents
|
May 22, 2018
Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections
David B Huang, G Ralph Corey, Thomas L Holland, et al.
Journal of Clinical Microbiology
|
October 23, 2009
Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial
In-Gyu Bae, Giang T Tonthat, Martin E Stryjewski, et al.
BMC Infectious Diseases
|
June 3, 2014
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
Martin E Stryjewski, Arnold Lentnek, William O'Riordan, et al.
Critical Care Medicine
|
December 20, 2007
Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia
Anna Lisa Crowley, Gail E Peterson, Daniel K Benjamin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2005
Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia
Vance G Fowler, Anita Justice, Catrin Moore, et al.
Page
of 16